PRIME-BOOST-IMPFSTOFFE GEGEN MALARIA

European patent · EP1802336 · Deleted

Register entry

Publication number
EP1802336
Application number
EP05808091
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Oct 13, 2005
Published
Jul 4, 2007
Granted
Sep 7, 2011
Deleted
Oct 31, 2013
Reason
Annual fee unpaid
IPC classes
A61K 39/015 (2006.01)
Priority
US 619056 P 14.10.2004
EP 04105035 14.10.2004
PCT application
PCT/EP2005/055209 13.10.2005
PCT publication
WO2006/040334 20.04.2006
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 21, 2014

    Deleted, fee unpaid

    Published in Swissreg on 21.05.2014

  2. Nov 30, 2011

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 30.11.2011

  3. Sep 7, 2011

    Granted

    Published in Swissreg on 07.09.2011

Parties

Holder

Crucell Holland B.V.

Archimedesweg 4, 2333 CN Leiden, NL

GlaxoSmithKline Biologicals SA

Rue de l'Institut 89, 1330 Rixensart, BE

The Government of the United States, as represen- ted by the Secretary of the Army, on behalf of the Walter Reed Army Instit

503 Robert Grant Avenue, Silver Spring, MD 20910-7500, US

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

PAU, Maria Grazia

NL-2333 CW Leiden, NL

GOUDSMIT, Jaap

NL-1075 CX Amsterdam, NL

COHEN, Joseph D., GlaxoSmithKline

B-1330 Rixensart, BE

DUBOIS, Patrice M., GlaxoSmithKline

B-1330 Rixensart, BE

STEWART, V. Ann

Silver Spring, Maryland 20910-7500, US

HEPPNER, Donald

Silver Spring, Maryland 20910-7500, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.